Filed: 2/14/2025ACC: 0001104659-25-014093
📋 What this filing means
RIDGEBACK CAPITAL INVESTMENTS L.P. filed this quarterly 13F‑HR report disclosing 1 equity positions with a total reported market value of $560.4K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
1
Positions
$560.4K
Total AUM (reported)
359.23K
Total Shares
Allocation by class
COM$560.4K100.0%
Portfolio Concentration
Top 3$560.4K100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 359.23K
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
359.23K
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole1
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings1
Rows:
Pyxis Oncology Inc
SOLEShares359.23K
TypeSH
Market value$560.4K
100.00%
Sole
0.00
Shared
0.00
None
359.23K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Pyxis Oncology IncSOLE | COM | 359.23K | SH | $560.4K 100.00% | 0.00 | 0.00 | 359.23K |